Internal Medicine · Johnson City, TN
NPI
1023067378
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
301 Med Tech Pkwy, Ste. 280
Johnson City, TN, 37604
Phone (423) 794-5550
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
6,039 services
Medicare patients, 2024
231
Average age 74
Drug cost, 2024
$964K
11,066 prescriptions
Company payments, 2025
$802
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Z Pearson was code J0897 (injection, denosumab, 1 mg), 1,200 times for 13 patients. In total Michael Z Pearson billed 6,039 services in 105 codes, and Medicare paid $161K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,200 | 13 | $20.59 | $25K |
| 36415 Venipuncture Blood Collection | Office | 572 | 200 | $8.65 | $4,948 |
| 99214 Office E&M - Established | Office | 356 | 176 | $79.44 | $28K |
| 80053 Clinical Chemistry | Office | 351 | 182 | $10.35 | $3,633 |
| 99213 Office E&M - Established | Office | 333 | 154 | $56.67 | $19K |
| 80061 Clinical Chemistry | Office | 299 | 178 | $13.12 | $3,923 |
| 85025 Blood Count | Office | 282 | 171 | $7.61 | $2,146 |
| 84443 Clinical Chemistry | Office | 229 | 166 | $16.46 | $3,769 |
| 81001 Clinical Chemistry | Office | 196 | 94 | $3.11 | $610 |
| 82306 Clinical Chemistry | Office | 176 | 120 | $29.01 | $5,106 |
| 83036 Blood Count | Office | 166 | 107 | $9.52 | $1,580 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 147 | 147 | $118.06 | $17K |
| 81003 Clinical Chemistry | Office | 101 | 88 | $2.20 | $222 |
| 82607 Clinical Chemistry | Office | 96 | 69 | $14.78 | $1,419 |
| 80048 Clinical Chemistry | Office | 90 | 50 | $8.29 | $746 |
By year: 2022 $152K for 6,111 services; 2023 $153K for 5,483 services; 2024 $161K for 6,039 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 572 | 200 | $8.65 | $4,948 |
| 80053 Clinical Chemistry | 351 | 182 | $10.35 | $3,633 |
| 80061 Clinical Chemistry | 299 | 178 | $13.12 | $3,923 |
| 85025 Blood Count | 282 | 171 | $7.61 | $2,146 |
| 84443 Clinical Chemistry | 229 | 166 | $16.46 | $3,769 |
| 81001 Clinical Chemistry | 196 | 94 | $3.11 | $610 |
| 82306 Clinical Chemistry | 176 | 120 | $29.01 | $5,106 |
| 83036 Blood Count | 166 | 107 | $9.52 | $1,580 |
| 81003 Clinical Chemistry | 101 | 88 | $2.20 | $222 |
| 82607 Clinical Chemistry | 96 | 69 | $14.78 | $1,419 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Z Pearson prescribed most often to Medicare patients was Losartan Potassium, with 550 prescriptions and refills. In total Michael Z Pearson wrote 11,066 Medicare prescriptions that cost $964K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 550 | 1,535 | 145 | $5,610 |
| Atorvastatin Calcium Generic | 549 | 1,419 | 136 | $5,486 |
| Amlodipine Besylate Generic | 462 | 1,251 | 123 | $2,626 |
| Rosuvastatin Calcium Generic | 426 | 1,250 | 131 | $5,207 |
| Omeprazole Generic | 416 | 1,023 | 111 | $9,581 |
| Levothyroxine Sodium Generic | 376 | 989 | 88 | $3,103 |
| Lisinopril Generic | 373 | 1,012 | 95 | $2,613 |
| Hydrochlorothiazide Generic | 294 | 802 | 75 | $1,418 |
| Potassium Chloride Generic | 288 | 696 | 77 | $6,615 |
| Gabapentin Generic | 249 | 341 | 58 | $4,184 |
| Montelukast Sodium Generic | 248 | 601 | 64 | $3,100 |
| Sertraline Hcl Generic | 215 | 483 | 50 | $2,131 |
| Tamsulosin Hcl Generic | 210 | 589 | 61 | $3,353 |
| Celecoxib Generic | 190 | 487 | 59 | $4,774 |
| Pantoprazole Sodium Generic | 150 | 376 | 42 | $1,854 |
Brand drugs: 1,177 claims; generic drugs: 9,839 claims; opioid claims: 123.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Z Pearson $802 ($802 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $197.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 12 | $197 |
| Novo Nordisk Inc NVO | 5 | $93.98 |
| Pfizer Inc. PFE | 5 | $83.47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $72.65 |
| Xeris Pharmaceuticals, Inc. | 3 | $69.95 |
| Lilly USA, LLC LLY | 3 | $50.61 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $46.19 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $44.5 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $23.43 |
| Inspire Medical Systems, Inc. INSP | 1 | $21.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.